Publication | Open Access

Comparative external validation of the PRECISE-DAPT and PARIS risk scores in 4424 acute coronary syndrome patients treated with prasugrel or ticagrelor

Percutaneous Coronary InterventionThrombosisEpidemiologyParis Risk ScoresCardiovascular EpidemiologyCardiovascular DiseaseClinical EpidemiologyComparative External ValidationPreventive CardiologyPublic HealthMedicineCardiologyCardiovascular Disease Risk AssessmentCoronary Artery DiseaseAcute Myocardial InfarctionMyocardial Infarction